Management of Oral Candidiasis (Thrush)

Physical Findings and Initial Management

• The characteristic white plaques of oral thrush detach easily with a compress, revealing an erythematous base, and they disappear completely after appropriate antifungal therapy. 1

First‑Line Antifungal Therapy for Mild‑to‑Moderate Disease

• In patients with mild oral candidiasis, clotrimazole troches 10 mg taken five times daily for 7–14 days are recommended as the primary regimen. 1
• A muco‑adhesive miconazole tablet 50 mg once daily for 7–14 days is an effective alternative first‑line option. 1
• Nystatin oral suspension (≈100 000 U/mL), 4–6 mL four times daily for 7–14 days, can be used as another alternative. 1

Treatment of Moderate‑to‑Severe Disease

• For moderate or severe oral candidiasis, oral fluconazole 100–200 mg once daily for 7–14 days is strongly recommended. 1
• The majority of patients show clinical response within 7 days after initiating antifungal therapy. 2

Management of Refractory Candidiasis

• Itraconazole solution 200 mg once daily or posaconazole suspension 400 mg twice daily for 3 days followed by 400 mg daily is advised for fluconazole‑refractory cases. 1
• Voriconazole 200 mg twice daily provides an effective alternative when other agents fail. 1
• Intravenous echinocandins (caspofungin, micafungin, anidulafungin) or amphotericin B deoxycholate 0.3 mg/kg daily are additional options for resistant infections. 1

Special Situations

Dental Prostheses

• Disinfection of dental prostheses together with systemic or topical antifungal therapy is essential to prevent recurrence. 1

HIV‑Infected Patients

• Optimizing antiretroviral therapy is strongly recommended to lower the risk of recurrent oral candidiasis. 1
• Chronic suppressive fluconazole 100 mg three times weekly may be required for patients with frequent relapses. 1

Pathogen Resistance and Alternative Therapies

• Nakaseomyces glabratus (formerly Candida glabrata) and Pichia kudriavzevii often persist despite standard regimens because of intrinsic antifungal resistance; susceptibility testing and treatment with echinocandins or amphotericin B are usually necessary. 2

Prognosis and Recurrence

• Classic pseudomembranous candidiasis (white plaques) generally resolves completely with appropriate therapy, typically within 7–14 days of treatment initiation. [1][2]
• Recurrences are common in immunocompromised individuals if the underlying predisposing factor is not addressed. 2

Antifungal Management of Oral Candidiasis

Mild Disease Treatment

• Clotrimazole troches 10 mg five times daily for 7–14 days are recommended as first‑line therapy for mild oral candidiasis. 3
• Miconazole mucoadhesive buccal tablets 50 mg once daily for 7–14 days constitute an alternative first‑line option. 4
• Nystatin oral suspension (≈100,000 U/mL) 4–6 mL four times daily for 7–14 days can be used when azole agents are unsuitable. 3

Moderate to Severe Disease Treatment

• Fluconazole oral 100–200 mg daily for 7–14 days is strongly recommended (high‑quality evidence) for moderate to severe oral candidiasis. 3

Special Considerations

Denture‑Associated Candidiasis

• Effective management requires both antifungal therapy and thorough disinfection of the denture prosthesis. 3

HIV‑Positive Patients

• Optimization of antiretroviral therapy is essential to reduce the incidence of recurrent oral candidiasis. 3

Chronic Suppressive Therapy

• Routine chronic suppressive antifungal therapy is generally not necessary; however, in patients with frequent recurrences, fluconazole 100 mg three times weekly may be employed. 3